UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000026004
Receipt number R000029850
Scientific Title Safety evaluation study about rituximab therapy for refractory pemphigus
Date of disclosure of the study information 2017/03/08
Last modified on 2021/03/04 18:59:20

No. Disposal Last modified on Item of update
1 Insert 2017/02/04 16:56:39
2 Update 2017/02/04 17:04:14 Name of secondary funder(s)
Name of secondary funder(s)
3 Update 2017/03/08 17:05:58 Key secondary outcomes
Key secondary outcomes
4 Update 2017/03/08 17:08:06 Date of disclosure of the study information
5 Update 2017/03/08 17:17:49 Public title
6 Update 2017/05/05 09:28:06 Public title
7 Update 2017/05/05 09:31:24 Key exclusion criteria
Key exclusion criteria
8 Update 2017/05/05 09:34:22 Recruitment status
Anticipated trial start date
9 Update 2018/08/07 13:23:48 Last name of contact person
Last name of contact person
Email
Name of person sending information
Name of person sending information
Email
10 Update 2021/03/04 18:45:41 Target sample size
11 Update 2021/03/04 18:52:35 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Email
Name of person sending information
Name of person sending information
Email
Organization1
Tel1
Organization
Organization
Address
Address
Tel
Email
Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
12 Update 2021/03/04 18:59:20 Date of IRB
Anticipated trial start date
Last follow-up date